Abstract
In Brazil, dependence on imports for pharmaceutical and agrochemical raw materials is significant. The development of new organic molecules, especially on an industrial scale, is crucial to reduce this dependence and promote the country as an exporter of high-value-added inputs. Investments in research are necessary to synthesize new molecules with pharmacological properties, minimizing s…